1. The effect of ivabradine as part of standard therapy on vascular endothelial function and cardiac electrical instability in patients with post-infarction cardiosclerosis and heart failure
- Author
-
A. A. Abdullaev, S. N. Mammaev, A. A. Anatova, U. A. Islamova, and A. M. Makhacheva
- Subjects
heart failure ,postinfarction period ,endothelial dysfunction ,heart rate variability ,24-hour holter monitoring ,ivabradine ,nebivolol ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Aim. To reveal the equivalence of nebivolol replacement with ivabradine in the prevention of endothelial dysfunction and cardiac electrical instability in patients with heart failure with reduced ejection fraction (HFrEF).Material and methods. In current observational study, 126 patients with HFrEF in the postinfarction period were randomized into two groups for six-month treatment: group 1 (n=62) — standard therapy (acetylsalicylic acid 0,1 g/day, clopidogrel 75 mg/day, veroshpiron 50 mg/day, nebivolol 5 mg/day, perindopril 5 mg/day and rosuvastatin 20 mg/day; group 2 (n=66) — the same therapy with nebivolol replacement with ivabradine 10 mg/day. Initially and after 6 months, 24-hour Holter monitoring was performed, heart rate variability was determined. We also investigated endothelial dysfunction using the photoplethysmographic technique with post-occlusive reactive hyperemia (PORH) test.Results. The heart rate, the number of episodes and the duration of symptomatic and silent myocardial ischemia, total myocardial ischemia were significantly decreased in both groups (p0,05). In both groups, after therapy, parameters of heart rate variability were improved with the parasympathetic predominance (p
- Published
- 2020
- Full Text
- View/download PDF